180 Wealth Advisors’s ResMed RMD Stock Holding History

180 Wealth Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-745	Closed	-$205K	–	398
2021 Q2	$205K	Buy	+745	New	+$157K	0.05%	341

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

180 Wealth Advisors's RMD Position: Q3 2021 in Review

180 Wealth Advisors sold out of ResMed (RMD) in Q3 2021, closing a stake of 745 shares — an estimated $205K sold.

180 Wealth Advisors first reported a position in RMD in Q2 2021 and held it in 1 quarter. The position peaked at $205K in Q2 2021. 686 funds tracked by Wall St. Rank hold RMD as of Q3 2021.

180 Wealth Advisors reported no remaining ResMed position as of Q3 2021 after selling out during the quarter.
180 Wealth Advisors sold 745 ResMed shares in Q3 2021, an estimated $205K.
180 Wealth Advisors first reported a position in ResMed in Q2 2021 and held it in 1 quarter.
180 Wealth Advisors's ResMed position peaked at $205K in Q2 2021.
686 funds tracked by Wall St. Rank held ResMed as of Q3 2021.

Based on 180 Wealth Advisors's 13F filing for Q3 2021, filed 28 Oct 2021.